Delivery Order SPE2DB20D7059-SPE2DB23FPUN1
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,013,510 units of Ciprofloxacin HCL 250 mg tablets, a generic antibiotic medication. The contract has a ceiling value of $1,165.86 and a completion date of January 23, 2025. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC)...
- This federal contract award is for the delivery of 4,558,280,789 units of Ciprofloxacin HCL 250 mg tablets to the Defense Logistics Agency (DLA). The $1,032.68 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on August 30, 2022, with an ultimate completion date of August 31, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,998.55, is for the delivery of 4,566,893,068 units of Ciprofloxacin HCL 250 mg tablets. The contract has an ultimate completion date of January 13, 2025. This award is not associated with a set-aside program. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,268.14, is for the delivery of 4,564,570,851 units of Ciprofloxacin HCL 250 mg tablets in 100-count bottles. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of May 13, 2024. There is no set-aside designation for this award....
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,563,681,935 units of Ciprofloxacin HCL 250 mg tablets. The contract has a ceiling value of $4,407.09 and a completion date of February 16, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
- This federal contract award is for the delivery of 4,557,636 units of Ciprofloxacin HCL 250 mg tablets to the Defense Logistics Agency (DLA). The $1,429.57 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on June 24, 2022, with a completion date of June 27, 2022. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $21,548.05, is for the delivery of 4,562,594,736 units of Ciprofloxacin HCL 500 mg tablets. The contract is a firm fixed-price delivery order that runs through October 26, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
- This federal contract award is valued at $2,949.01 and was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, as a delivery order. The contract is for the supply of 4,565,860,584 units of Ciprofloxacin HCL 250 MG tablets, a generic antibiotic medication. The contract has a firm fixed price and an ultimate completion date of September 19, 2024. This award is not associated with a set-aside program. AmerisourceBergen holds significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,557,612,521 units of Ciprofloxacin HCL 250 mg tablets. The $6,184.04 firm fixed-price delivery order has a completion date of June 23, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,515.39 firm fixed-price delivery order contract is for the supply of 4,563,827,363 units of Ciprofloxacin HCL 250 mg tablets. The contract has an ultimate completion date of March 4, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB23FPUN1Delivery Order
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,808.86, is a delivery order for 4,559,295,117 units of Ciprofloxacin HCL 250 MG Tablets. It is a firm-fixed price contract with a completion date of December 8, 2022. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This award is part of that broader IDC. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 12/7/22 |